Long term renal toxicity of ifosfamide in adult patients - 5 year data

European Journal of Cancer

Volumn 48, Issue 9, 2012, Pages 1326-1331

  Farry, James K ^a   Flombaum, Carlos D ^b   Latcha, Sheron ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Ifosfamide; Long term nephrotoxicity; Nephrotoxicity; Renal complications

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE; AMPHOTERICIN; CARBOPLATIN; IFOSFAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG EFFECT; DRUG EXPOSURE; DRUG MEGADOSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CARBOPLATIN; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IFOSFAMIDE; KIDNEY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME; YOUNG ADULT;

EID: 84861338607     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.03.009     Document Type: Article

References (14)

1. R. Skinner, A.D. Pearson, L. Price, M.G. Coulthard, and A.W. Craft The influence of age on nephrotoxicity following chemotherapy in children Br J Cancer Suppl 18 1992 S30 35
2. R. Rossi, A. Godde, and A. Kleinebrand Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients J Clin Oncol 12 1 1994 159 165
3. E.L. Zaki, J.E. Springate, and M. Taub Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells Toxicol In Vitro 17 4 2003 397 402
4. M. Furlanut, and L. Franceschi Pharmacology of ifosfamide Oncology 65 suppl. 2 2003 2 6
5. B.J. Morland, J.R. Mann, D.V. Milford, F. Raafat, and M.C. Stevens Ifosfamide nephrotoxicity in children: histopathological features in two cases Med Pediatr Oncol 27 1 1996 57 61
6. P.C. Koch Nogueira, A. Hadj-Aissa, M. Schell, L. Dubourg, M. Brunat-Mentigny, and P. Cochat Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma Pediatr Nephrol 12 7 1998 572 575
7. L.A. Stevens, and A.S. Levey Use of the MDRD study equation to estimate kidney function for drug dosing Clin Pharmacol Ther 86 5 2009 465 467
8. G.M. Marx, G.M. Blake, and E. Galani Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients Ann Oncol 15 2 2004 291 295
9. M.P. Goren, R.K. Wright, and C.B. Pratt Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy Cancer Res 47 5 1987 1457 1460
10. R. Shore, M. Greenberg, D. Geary, and G. Koren Iphosphamide-induced nephrotoxicity in children Pediatr Nephrol 6 2 1992 162 165
11. D.M. Townsend, M. Deng, L. Zhang, M.G. Lapus, and M.H. Hanigan Metabolism of cisplatin to a nephrotoxin in proximal tubule cells J Am Soc Nephrol 14 1 2003 1 10
12. G. Ciarimboli, T. Ludwig, and D. Lang Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2 Am J Pathol 167 6 2005 1477 1484
13. J.T. Hartmann, L.M. Fels, and A. Franzke Comparative study of the acute nephrotoxicity from standard dose cisplatin ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide Anticancer Res 20 5C 2000 3767 3773
14. R. Skinner, A. Parry, L. Price, M. Cole, A.W. Craft, and A.D. Pearson Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose Pediatr Blood Cancer 54 7 2010 983 989